openPR Logo
Press release

Radiopharmaceuticals Market to Grow at a CAGR of 7.3% from 2023 to 2031, Reaching US$ 8.5 Billion: As per TMR Study

02-26-2024 10:21 AM CET | Health & Medicine

Press release from: Transparency Market Research

Radiopharmaceuticals

Radiopharmaceuticals

The global ๐‘๐š๐๐ข๐จ๐ฉ๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ is projected to reach a value of US$ 8.5 Bn by 2031 end, itย  is anticipated to grow at a CAGR of 7.3% during the forecast period.

Radiopharmaceuticals are basically unique therapeutic compositions that incorporate radioisotopes. These radiopharmaceuticals are utilized for both diagnosis and treatment. Radiopharmaceuticals are classified into four different categories, which are radiopharmaceutical preparation, radionuclide generator, radiopharmaceutical precursor, and radiopharmaceutical preparation kit.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐…:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=213&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐š๐ง๐ ๐‚๐ก๐š๐ฅ๐ฅ๐ž๐ง๐ ๐ž๐ฌ:

Key drivers fueling market growth include the increasing incidence of cancer and cardiovascular diseases, growing geriatric population, and expanding applications of nuclear medicine in disease diagnosis and treatment.

However, challenges such as regulatory constraints, high costs associated with radiopharmaceutical production, and logistical issues may hinder market expansion.

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ:

Emerging trends in the radiopharmaceuticals market include the development of novel radiotracers for targeted imaging and therapy, collaborations between pharmaceutical companies and research institutions to enhance R&D capabilities, and the integration of artificial intelligence in imaging interpretation for improved diagnostic accuracy.

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ ๐‚๐จ๐ฏ๐ž๐ซ๐ž๐-

Cardinal Health, Advanced Accelerator Applications, A Novartis Company, Lantheus, Curium, GE HealthCare, Jubilant Radiopharma, A Jubilant Pharma Company, China lsotope & Radiation Corporation., Siemens Healthcare GmbH, Bracco, NTP, Eckert & Ziegler, SHINE Technologies, LLC, EczacฤฑbaลŸฤฑ-Monrol, IBA Worldwide, Global Medical Solutions, BWX Technologies. Inc, Institute of Isotopes, Coquรญ Radiopharmaceuticals Corp., Evergreen Theragnostics, Inc., Isotope JSC, and PharmaLogic Holdings Corp. among others

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง-

๐‚๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐

Fluorine-18 derivatives
Fluorine-18 Fludeoxyglucose (FDG)
Fluorine-18 Sodium Fluoride
Fluorine-18 Flucicovine
Fluorine-18 Florbetapir
Fluorine-18 Florbetaben
Others

Technetium-99
Lutetium (Lu) 177
Gallium-68
Dotatate
Dotatoc
Zirconium 89
11C-choline
14C-urea
Others

๐’๐ฒ๐ฌ๐ญ๐ž๐ฆ

PET
Standalone PET Systems
Hybrid PET/CT
Hybrid PET/MRI
SPECT

๐ˆ๐ง๐๐ข๐œ๐š๐ญ๐ข๐จ๐ง

Oncology
Neurology
Neurodegenerative Diseases (AD, PD, and Others)
Epilepsy
Cardiology
Others

๐„๐ง๐-๐ฎ๐ฌ๐ž๐ซ

Hospitals
Diagnostic Labs
Others

๐๐ฅ๐š๐œ๐ž ๐š๐ง ๐Ž๐ซ๐๐ž๐ซ ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
https://www.transparencymarketresearch.com/checkout.php?rep_id=213<ype=S&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ

North America(USA, Canada and Mexico)
Europe(UK, Germany, France and the Rest of Europe)
Asia Pacific(China, Japan, India, and the Rest of the Asia Pacific region)
South America(Brazil, Argentina and the Rest of South America)
Middle East and Africa(GCC and Rest of the Middle East and Africa)

๐…๐ฎ๐ญ๐ฎ๐ซ๐ž ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:

The future outlook for the radiopharmaceuticals market remains optimistic, driven by ongoing technological advancements, increasing investments in nuclear medicine infrastructure, and growing awareness about the benefits of molecular imaging and targeted therapy.

๐๐ซ๐จ๐ฐ๐ฌ๐ž ๐Œ๐จ๐ซ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐“๐Œ๐‘:

๐๐จ๐ญ๐š๐ฌ๐ฌ๐ข๐ฎ๐ฆ ๐’๐ฎ๐ฅ๐Ÿ๐š๐ญ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ- https://www.globenewswire.com/news-release/2023/05/29/2677921/0/en/Potassium-Sulfate-Market-Set-to-Achieve-USD-10-8-Billion-Revenue-by-2031-with-4-9-CAGR-TMR-Study.html

๐‡๐ฒ๐ ๐ข๐ž๐ง๐ž ๐๐š๐œ๐ค๐š๐ ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ- https://www.globenewswire.com/news-release/2023/05/29/2677908/0/en/Hygiene-Packaging-Market-to-Grow-at-a-CAGR-of-6-3-from-2023-to-2031-Reaching-US-85-5-Billion-Exclusive-Report-by-Transparency-Market-Research.html

๐€๐›๐จ๐ฎ๐ญ ๐“๐ซ๐š๐ง๐ฌ๐ฉ๐š๐ซ๐ž๐ง๐œ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก

Transparency Market Research, a globalย market research companyย registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ:

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website:ย https://www.transparencymarketresearch.comย ย ย ย  ย ย 
Email:ย sales@transparencymarketresearch.com
Follow Us:ย LinkedIn|ย Twitter|ย Blogย |ย YouTube

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Radiopharmaceuticals Market to Grow at a CAGR of 7.3% from 2023 to 2031, Reaching US$ 8.5 Billion: As per TMR Study here

News-ID: 3398818 • Views: โ€ฆ

More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 - Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 โ€ฆ
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth. Uncover essential discoveries and trends fromโ€ฆ
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Radiopharmaceuticals to Propel Market Expansion | Transparency Market Research, Inc
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra โ€ฆ
The global Technetiumโ€99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth. Discover essential conclusions and data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100 Analysts' Viewpoint The Technetiumโ€99mโ€ฆ
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to US$ 280 Million by 2030, Driven by Rising Equine Diseases and Diagnostic Advancements
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to โ€ฆ
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equineโ€ฆ
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of 6.1%
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of โ€ฆ
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,โ€ฆ

All 5 Releases


More Releases for Radiopharma

Nuclear Pharmacy Market Future Business Opportunities 2025-2032 | Curium Pharma, โ€ฆ
The Latest study titled Nuclear Pharmacy Market 2025, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2025 to 2032. The comprehensive research delves into the evolving market dynamics, value chain analysis, prominent investment areas, competitive landscape, regional outlook, and key market segments. It also offers a thorough assessment of the global market's drivers and constraints. Additionally, the reportโ€ฆ
Actinium Pharmaceuticals (ATNM) Garners Attention with Clinical Successes and St โ€ฆ
Actinium's Chief Medical Officer, said, "In addition to demonstrating unprecedented 100% access to BMT in Iomab-B treated patients with active r/r AML and achieving the primary endpoint of dCR with high statistical significance, we are excited by the compelling outcomes in patients with a TP53 mutation in the SIERRA trial. We look forward to returning to EBMT and once again highlighting the positive results from the Phase 3 SIERRA trialโ€ฆ
Actinium Pharmaceuticals (ATNM): A Prime Buyout Candidate Amidst a Radiopharma A โ€ฆ
Biotech Stocks Taking Centerstage As the pharmaceutical industry ventures deeper into the era of precision medicine, radiopharmaceuticals, particularly those involving alpha emitters like Actinium-225 (Ac-225), are gaining prominence for their targeted approach to cancer treatment. Amid this innovative surge, Actinium Pharmaceuticals (NYSE:ATNM) emerges not just as a company with a promising pipeline but as a beacon of cutting-edge manufacturing capabilities that could very well position it as a prime buyout candidateโ€ฆ
2030 Projections: Radiopharmaceutical Synthesizers Market to Deliver Dynamic Pro โ€ฆ
The Radiopharmaceutical Synthesizers Market Research Report 2023-2030 provides in-depth information on market trends, market capacity, industry size, growth factors, share, innovations, competitive environment, business problems, and more. This report's historical data confirms demand growth on a global, national, and regional scale. The studies on the global industry cover everything from comprehensive research to market size and forecasting to dynamics, growth factors, prospects, and hazards, as well as vendor knowledge. Theโ€ฆ
Automated Radiosynthesis Modules Market Strategic Assessment & SWOT Analysis 202 โ€ฆ
An Informative report titled as Global Automated Radiosynthesis Modules Market has recently been published by Report Consultant to its online repository. This statistical data offers an in-depth analysis by considering several segments, such as type, size, technology and applications. Different exploratory techniques such as, qualitative and quantitative analysis have been used to give data accurately. For better understanding of the customers, it uses effective graphical presentation techniques, such as graphs,โ€ฆ
Cyclotron Market Growth Opportunities Analysis Report | GE Healthcare, Siemens H โ€ฆ
Cyclotron Market: Introduction According to the report, the globalย cyclotron marketย was valued at US$ย 215.5ย Mn in 2019. It is projected to expand at a CAGR of ~3% from 2020 to 2030. Expansion activities of key radiopharma players; applications in clinical trials; increase in the geriatric population; pipeline assessment of new drugs; and disease indication mortality are major factors driving the cyclotron market. The shutdown of a few nuclear reactors has led to theโ€ฆ